Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conditioned Pharmacotherapeutic Effects in Hypertension
NCT02056626Phase 4Completed
- Sponsor
- University of Rochester
- Start
- Mar 2011
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of carvedilol in hypertension (HTN) (4 arms), sponsored by University of Rochester. Primary endpoint: Mean Systolic Blood Pressure at Day 30. Started Mar 2011; status: completed.
02
Drugs
carvedilol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02056626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02056626.